Adamis Pharmaceuticals Corp - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ADMP Nasdaq 2834 http://www.adamispharmaceuticals.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Adamis Pharmaceuticals Corp

Have Insiders Been Selling Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Shares? - Jun 20th, 2019 8:02 am
Adamis Pharmaceuticals Provides Update on Its Higher Dose Naloxone Injection Product - Jun 11th, 2019 7:00 am
Adamis Pharmaceuticals Announces Patent Litigation Regarding Its Higher Dose Naloxone Injection Product - May 21st, 2019 6:30 am
Adamis Pharmaceuticals Announces Conditional Acceptance by FDA of Proprietary Name for Higher Dose Naloxone Product - May 14th, 2019 7:00 am
Edited Transcript of ADMP earnings conference call or presentation 9-May-19 9:00pm GMT - May 13th, 2019 7:06 pm
Adamis Pharmaceuticals (ADMP) Reports Q1 Loss, Misses Revenue Estimates - May 9th, 2019 3:55 pm
Adamis: 1Q Earnings Snapshot - May 9th, 2019 2:51 pm
Adamis Pharmaceuticals Announces First Quarter 2019 Financial Results and Business Update - May 9th, 2019 2:30 pm
Adamis Pharmaceuticals Schedules First Quarter 2019 Earnings Conference Call and Business Update - May 7th, 2019 7:00 am
Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - May 2nd, 2019 8:32 am
Adamis Pharmaceuticals Announces 2018 Financial Results and Provides Business Update - Mar 15th, 2019 2:39 pm
The Daily Biotech Pulse: KaryoPharm's Selinexor Review Delayed, FDA Accepts Adamis Opioid Overdose Drug NDA - Mar 15th, 2019 5:39 am
Adamis Pharmaceuticals Announces FDA Acceptance for Review of the New Drug Application of Its Higher Dose Naloxone Injection Product Candidate - Mar 14th, 2019 2:55 pm
Before You Buy Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Consider Its Volatility - Mar 13th, 2019 9:51 am
The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings - Feb 27th, 2019 6:13 am
Adamis Provides Regulatory Update on Sublingual Tadalafil - Feb 26th, 2019 4:54 pm
Adamis Pharmaceuticals Publishes the Rationale for a Higher Dose Naloxone Product to Counter the Current Opioid Epidemic - Feb 20th, 2019 7:00 am
Is Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Excessively Paying Its CEO? - Jan 23rd, 2019 11:51 am
The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US - Jan 17th, 2019 6:06 am